Latest advances and outcomes from the treatment of acute leukemia today

Latest advances and outcomes from the treatment of acute leukemia today

Leukemia is a blood cancer that can be identified by the rapid growth of defective

blood cells. The marrow of our bone produces most of the blood in our body which is

the site of this abnormal growth. Typically, leukemia cells are immature white blood

cells. Leukemic cells alter the normal blood cell formation process, leading to various

signs and symptoms such as bleeding, infection, and tiredness.

There are two kinds of leukemia: acute leukemia and chronic leukemia. Further, the

acute type was classified into acute myeloid leukaemia (AML) and acute

lymphoblastic leukaemia (ALL). Myeloblasts, or defective white blood cells, are the

cause of acute myeloid leukaemia (AML). Acute myelogenous, granulocytic,

nonlymphocytic, or myeloblastic leukaemia are other terms for this kind of cancer.

However, the overproduction of lymphocytes is caused by acute lymphoblastic

leukaemia (ALL).

Stem cell transplantation, radiation therapy, and chemotherapy have been the

cornerstones of leukaemia treatment. Targeted therapy has also been included in the

standard of care for certain kinds of leukaemia within the past 20 years. These

medications target the proteins that regulate the growth, division, and metastasis of

cancer cells. Different treatment combinations are needed for different forms of

leukaemia.

For Acute lymphocytic leukemia (ALL), Immunotherapies are being used where

many elderly people are unable to handle the severe side effects of the intense

chemotherapy therapies required to treat ALL. Compared to chemotherapy, targeted

therapies might have fewer adverse effects.

Immunotherapies are treatments that enhance the body's ability to fight cancer

through the immune system. Currently, four immunotherapies are FDA approved for

the treatment of ALL: blinatumomab, inotuzumab ozogamicin, tisagenlecleucel and

midostaurin. In ALL, the following immunotherapy techniques are being tested or

employed are CAR T-cell therapy and bispecific T-cell engagers (BiTEs). A sort of

cancer treatment called CAR T-cell therapy involves genetically modifying the

patient & own immune cells. For the treatment of some children and young adults with

ALL, one kind of CAR T cell therapy is currently approved. Dosing is based on

weight reported at the time of leukapheresis.The use of this type in elderly B-cell

ALL patients is now being investigated. Adults with B-cell precursor ALL who have

not responded to previous treatment or have returned after treatment have been

approved for another course of CAR T-cell therapy.

Bispecific T-cell engagers (BiTEs) are another immunotherapy that is being studied

for ALL. These medications bind to both cancer and immune cells, drawing the two

groups of cells closer together so that the immune cells can locate and eliminate the

cancer cells with ease. Recently, it was demonstrated that one such BiTE,

blinatumomab, can increase survival for ALL patients in remission following

chemotherapy, even in situations where the disease is completely eradicated.

 

Acute myeloid leukaemia (AML) tends to be aggressive and was harder to treat than

ALL. However, AML cells sometimes have gene changes that cause the tumors to

grow but can be targeted with new drugs. The management of AML involves two

phases such as remission induction therapy (first phase of treatment to kill

the  leukemia   cells  in the blood and  bone marrow ) and remission continuation therapy

(second phase of treatment to kill any remaining leukemia cells).

The treatment of AML includes chemotherapy (drugs to stop the growth of cancer

cells), radiation therapy (uses high-energy  x-rays  or other types of  radiation  to kill

cancer cells), stem cell transplant (to replace the blood-forming cells from the blood

or  bone marrow  of the patient) and targeted therapy (drugs or other substances to

identify and attack specific cancer cells) or combination of both. Targeted treatments

such as Enasidenib, Olutasidenib, Ivosidenib, Venetoclax, Gemtuzumab ozogamicin,

Midostaurin, Gilteritinib, Glasdegib, and Quizartinib have recently been approved to

treat AML with specific gene alterations.

In order to achieve complete remission (CR) from acute leukaemia, standard

treatment paradigms have involved high-intensity induction chemotherapy. In certain

cases, this was followed by an allogeneic hematopoietic cell transplant (allo-HCT) to

eliminate residual disease through the "graft versus leukaemia effect, which is

mediated by the immune cells of the donor. Allo-HCT is not recommended for all

patients, though, and one of the biggest problems facing the industry at the moment is

the lack of viable chemotherapy-based choices for patients who relapse after allo-

HCT or who develop chemotherapy-refractory illness.

The potential of immunotherapy in the treatment of acute myeloid leukaemia (AML)

has been established by the effectiveness of allogeneic stem cell transplantation.

Alternative T-cell-based immunotherapies have demonstrated effectiveness, but there

is a chance that they could cause on-target off-leukemia hematotoxicity. Currently,

the use of adoptive autologous or allogeneic chimeric antigen receptor (CAR) T /

natural killer cell treatment as a bridge-to-transplant approach is almost only available

in clinical studies.

Acute leukaemia used to be nearly always fatal, but now it has a 63% 5-year survival

rate in the US. The therapeutic options for acute leukaemia have increased with the

introduction of immunotherapy, however, the advancement in AML has been slower.

Novel medicines such as ADCs, CAR T cell treatments, and BiTEs continue to show

remarkable response rates and favourable toxicity profiles in various disease states

every year. Even with these developments, a large number of patients are still not

eligible for immunotherapeutic treatments, and relapses following some of the more

recent modalities are still linked to extremely poor prognoses. In the future, new

medicines with potentially unique mechanisms of action will probably be approved

together with the expansion of the indications for currently available medications.

References:

1. Leukemia. National Cancer Institute. Available at:

https://www.cancer.gov/types/leukemia/hp/adult-aml-treatment-pdq

2. Boyiadzis MM, Aksentijevich I, Arber DA, et al. The Society for Immunotherapy

of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of

acute leukemia. Journal for ImmunoTherapy of Cancer. 2020

 

3. Kantarjian, H., Kadia, T., DiNardo, C. et al. Acute myeloid leukemia: current

progress and future directions. Blood Cancer J. 2021

4. Subklewe M, Bücklein V, Sallman D, Daver N. Novel immunotherapies in the

treatment of AML: is there hope? Hematology Am Soc Hematol Educ Program. 2023

Dec 8;2023

Share:

More Posts

Understanding Sarcoma: A Rare but Treatable Cancer – With Expert Care at Healius Cancer and Haematology Clinics

Understanding Sarcoma: A Rare but Treatable Cancer – With Expert Care at Healius Cancer and Haematology Clinics Sarcoma is a rare group of cancers that begin in the bones or soft tissues such as fat, muscle, nerves, blood vessels, or connective tissues. Unlike more common cancers, sarcomas can occur anywhere in the body and are known for their diverse subtypes. They are broadly classified into bone sarcomas (like osteosarcoma and Ewing’s sarcoma) and soft tissue sarcomas (such as liposarcoma, leiomyosarcoma, and synovial sarcoma). 📊 Prevalence in India Sarcomas account for less than 1% of all adult cancers and around 15% of all childhood cancers. In India, the burden is slowly being recognized, particularly among the paediatric and young adult population. Due to their rarity, sarcomas are often misdiagnosed or diagnosed late, making expert multidisciplinary care crucial. 🧬 Causes and Hereditary Factors While the exact cause of sarcoma remains unknown in most cases, several risk factors have been identified: Genetic syndromes like Li-Fraumeni syndrome, Neurofibromatosis type 1, and hereditary retinoblastoma increase the risk. Radiation exposure from prior cancer treatment. Certain chemical exposures and chronic swelling (lymphedema). Some cases emerge without any known risk factors. 👶 Impact on Children Sarcomas like rhabdomyosarcoma and Ewing’s sarcoma are among the most common childhood cancers. These diagnoses can deeply affect the child’s physical growth, emotional development, and social interactions, making compassionate and comprehensive care essential. 👶 Impact on Children – Special Focus on Neural-Origin Sarcomas Sarcomas such as rhabdomyosarcoma, Ewing’s sarcoma, and osteosarcoma are among the most common in children. However, a smaller subset of paediatric sarcomas arises from the neural tissue, such as Malignant Peripheral Nerve Sheath Tumours (MPNST). These neural-origin sarcomas are often linked to genetic conditions like Neurofibromatosis type 1 (NF1) and may present as rapidly enlarging, deep-seated, and painful masses. Their aggressive behavior and potential to affect vital nerve structures make early diagnosis and expert management crucial. At Healius Cancer and Haematology Clinics, children with such rare tumours receive specialized, age-appropriate care under the guidance of Dr. Mangesh Kamath, with a focus on: Preserving neurological function Ensuring optimal tumour control Supporting the child’s psychological and developmental health Our team works closely with paediatric surgeons, neurologists, psychologists, and rehabilitation experts to deliver holistic care and improve long-term quality of life. 💊 Treatment Options at Healius Cancer and Haematology Clinics Under the expert guidance of Dr. Mangesh Kamath, a renowned medical oncologist, sarcoma patients at Healius receive personalized and evidence-based treatment plans that may include: Surgery to remove the tumor with maximum tissue preservation Radiation therapy for local control, especially when surgery isn’t feasible Chemotherapy for aggressive or metastatic disease Targeted therapy and immunotherapy in select cases based on genetic profiling Each patient benefits from a multidisciplinary tumor board discussion, ensuring optimal treatment planning and sequencing. ❤️‍🩹 Coping With Treatment and Beyond Sarcoma treatment can be intense and long-term, affecting both the patient and their family. At Healius, our holistic approach includes: Psychological counseling and emotional support Nutritional guidance to aid recovery and manage treatment side effects Physiotherapy and rehabilitation to restore function and mobility Survivorship care plans for long-term monitoring and quality of life We walk hand-in-hand with caregivers, providing education, support groups, and respite care resources. 🏥 Why Choose Healius Cancer and Haematology Clinics? At Healius, we believe every sarcoma patient deserves precision medicine with a human touch. Under the leadership of Dr. Mangesh Kamath, we combine advanced oncology with compassionate care. From diagnosis to survivorship, we ensure that no patient feels alone in their journey. Healius – where expertise meets empathy. Book an Appointment

Exercise & Cancer Recovery: How Physical Activity Can Lower Recurrence and Improve Quality of Life

Exercise & Cancer Recovery: How Physical Activity Can Lower Recurrence and Improve Quality of Life When it comes to cancer recovery and prevention, most patients focus on treatments such as chemotherapy, radiation, or surgery. However, emerging research and clinical insights are now highlighting another powerful ally in the fight against cancer — exercise. Dr. Mangesh P Kamath, Senior Consultant at Healius Cancer & Hematology Clinics, one of the leading cancer hospitals in Bangalore, emphasizes the role of regular physical activity in reducing the risk of cancer recurrence and improving survival outcomes. “Exercise can be done in different levels: low, moderate, and high intensity,” says Dr. Kamath. “Since it can be difficult for patients to do high-intensity exercises during or after cancer treatment, moderate exercises like brisk walking or sports like badminton are recommended.” According to studies and clinical experience, moderate physical activity can reduce the risk of cancer recurrence by nearly 30%. Moreover, more than one-third of patients showed a significantly lower risk of death when they incorporated exercise into their post-treatment lifestyle. More Than Just Colon Cancer While the benefits of exercise in preventing the recurrence of colon cancer are well known, Dr. Mangesh Kamath highlights that regular physical activity also plays a preventive role in other cancers such as breast cancer and lung cancer. “Not just colon cancer, exercise can also help prevent the risk of occurrence of many cancers, such as breast and lung cancer, increasing the overall quality of life,” he adds. Why Healius Emphasizes Holistic Cancer Care At Healius Cancer & Hematology Clinics, patient care goes beyond just medication. The team of expert oncologists and specialists believes in a holistic approach to cancer treatment — integrating physical well-being, emotional support, and long-term lifestyle management. Whether you’re undergoing active treatment or are in remission, our experts at Healius will guide you through safe, customized fitness plans that support your recovery journey. Your Next Step Towards Recovery If you or a loved one is navigating through cancer, it’s important to not only rely on medical treatments but also embrace lifestyle changes that improve outcomes. Exercise is one of the most accessible yet powerful tools you can use. For expert guidance and compassionate care, visit Healius Cancer & Hematology Clinics, a trusted cancer hospital in Bangalore offering evidence-based, patient-centered cancer treatment. Book a consultation with Dr. Mangesh P Kamath and take a step toward recovery with confidence. 📍 Healius Cancer & Hematology Clinics | Bangalore🌐www.healiuscancerhematology.com📞 Call us today to know more! +91 9900613143 Book an Appointment

Vaping: The Modern Danger Lurking Behind Flavored Smoke

Vaping: The Modern Danger Lurking Behind Flavored Smoke  An awareness blog by Healius Cancer & Hematology Clinics In recent years, vaping has become a popular trend—especially among teens and young adults—marketed as a “safer” alternative to smoking. But behind the fruity flavors and sleek devices lies a serious health risk that often goes unnoticed. At Healius Cancer & Hematology Clinics, we are committed to raising awareness about the dangers of vaping and how it can increase your risk of cancer.  What Exactly Is Vaping? Vaping involves inhaling an aerosol (commonly called vapor) produced by an electronic cigarette or similar device. These aerosols usually contain: Nicotine Ultrafine particles Volatile organic compounds Heavy metals like nickel, tin, and lead Cancer-causing chemicals such as formaldehyde and acrolein Though marketed as “cleaner” than cigarettes, these ingredients are far from safe.  Vaping and Cancer: What’s the Connection? Many of the chemicals found in vape liquids are known carcinogens, which means they can directly damage DNA and promote the growth of cancer cells. 1. Lung Cancer E-cigarette aerosols contain toxic compounds that can irritate lung tissue and trigger long-term inflammation—a key factor in cancer development. Several studies have shown that prolonged exposure can alter healthy cells, paving the way for lung cancer. 2. Oral and Throat Cancer Vaping increases the risk of oral cancers, especially due to the presence of formaldehyde and acetaldehyde. These chemicals attack the lining of the mouth and throat, just like tobacco products. 3. Bladder Cancer Toxins inhaled during vaping can accumulate in the bladder. Research has identified some cancer-causing substances in vape users’ urine, linking vaping to an increased risk of bladder cancer.  The Healius Perspective At Healius Cancer & Hematology Clinics, our specialists are seeing a disturbing trend: more young people developing early signs of respiratory illnesses, throat inflammation, and abnormal cellular changes linked to vaping. We strongly advocate for early screening and preventive health education, especially among adolescents and young adults.   Vaping Myths—Busted! “It’s just flavored water vapor.” False. The aerosol contains toxic and cancer-causing chemicals—not just water.  “It’s safer than smoking.” Misleading. While vaping may have fewer chemicals than traditional cigarettes, the damage it causes is still significant and potentially long-term.  “It doesn’t affect young people.” Untrue. Youth and teens are more vulnerable as their lungs and brain are still developing, increasing their susceptibility to nicotine addiction and long-term damage. What Can You Do? Educate your children and peers about the real dangers of vaping. If you vape, seek help to quit. There are safe, evidence-based programs available. Get screened. If you’re a regular vaper, talk to our experts about early detection and health monitoring.  Prevention is the Best Protection Your health is your most valuable asset. Don’t trade it for a moment of flavored smoke. At Healius Cancer & Hematology Clinics, we believe in empowering people with knowledge and preventive care to reduce cancer risks in our community. Book an Appointment

International Yoga Day: The Healing Power of Yoga for Cancer Patients

International Yoga Day: The Healing Power of Yoga for Cancer Patients Each year, June 21st is celebrated as International Yoga Day, a global reminder of the ancient Indian practice that harmonizes the body, mind, and spirit. At Healius Cancer & Hematology Clinics, we believe in blending modern medicine with holistic healing approaches—and yoga plays a powerful role in the journey of cancer care and recovery. Why Yoga Matters for Cancer Patients A cancer diagnosis can be physically exhausting and emotionally overwhelming. From managing treatment side effects to coping with fear, stress, and fatigue, the journey is often challenging. Yoga offers gentle yet impactful support throughout this journey. Here’s how: 1. Reduces Stress and Anxiety Breathing exercises and meditation help calm the mind and reduce anxiety levels. This mental peace can improve treatment response and emotional strength. 2. Improves Physical Strength and Flexibility Gentle yoga poses improve blood circulation, strengthen muscles weakened by chemotherapy or radiation, and enhance balance—helping patients regain control over their bodies. 3. Boosts Immunity Practicing yoga regularly can strengthen the immune system, which is crucial for cancer patients whose immunity is often compromised due to treatment. 4. Improves Sleep and Reduces Fatigue Restorative yoga and relaxation techniques enhance the quality of sleep, which is often disrupted during cancer treatment, and help in combating fatigue. 5. Promotes Emotional Well-being Yoga nurtures a sense of inner calm and positivity. It helps patients reconnect with themselves and build resilience during tough times. We understand that healing is not just about treating the disease—it’s about caring for the whole person. Our team encourages patients to explore yoga as a supportive therapy along with their medical treatment. This International Yoga Day, Let’s Embrace Holistic Healing Yoga is more than just exercise—it’s a lifeline for many on their cancer journey. At Healius, we stand by our patients every step of the way, combining cutting-edge cancer treatments with the healing touch of yoga.  Your path to recovery can be stronger, calmer, and more balanced—with yoga. Book an Appointment

Send Us A Message

Leave a Comment

Your email address will not be published. Required fields are marked *

Doctor Appointment Booking